ZFZhuoying Feng

Zhuoying Feng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zhuoying Feng has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Abirami Rajasekaran

    Department of Microbial Sciences in Health, Cleveland Clinic Research, Cleveland, OH 44195, USA

    1 shared publication
  • Andrew C. Kwong

    The Biological and Biomedical Sciences Program, Harvard Medical School, Boston, Massachusetts, USA

    1 shared publication
  • Bin Li

    MOE Key Laboratory of Tumor Molecular Biology and Guangdong Provincial Key Laboratory of Bioengineering Medicine, National Engineering Research Center of Genetic Medicine, Institute of Biomedicine, College of Life Science and Technology, Jinan University, Guangzhou, Guangdong 510632, PR China

    1 shared publication
  • Eun Hee Ha

    Department of Microbial Science in Health, Cleveland Clinic, Cleveland, Ohio, USA

    1 shared publication
  • Fanghang Zhou

    Department of Biomedical Sciences, City University of Hong Kong, Kowloon, Hong Kong, PR China

    1 shared publication
  • Gail A. M. Cresci

    Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA

    1 shared publication

Latest Publications

  • Open Access

    Role of L-Arginine in the Gut–Liver Axis of Female Mice: Mediating Ethanol’s Alterations in Hepatic Steatosis and Oxidative Stress

    by Kaitlyn Daff, Yingchun Han, Zhuoying Feng, Mala Upadhyay, Vyshnavi Sivampeta, Abirami Rajasekaran, Naseer Sangwan, Gail A. M. Cresci

    Ethanol exposure causes microbial imbalance, damages the gut barrier, and increases oxidative stress along the gut–liver axis, leading to the development and progression of alcohol-associated liver disease (ALD). Arginine is a conditionally essential amino acid that may play a key role in maintaining redox homeostasis and mediating host–microbiota crosstalk. We hypothesized that supplemental arginine provided during chronic ethanol exposure in mice would mitigate oxidative damage via the gut–liver axis. Our findings suggest that arginine supplementation mediated hepatic steatosis, preserved body weight and fat, and reduced oxidative stress in the gut–liver axis. These changes were associated with alterations in gut microbiota composition and function. These data support a potential role for arginine supplementation in mitigating ethanol-induced oxidative damage via the gut–liver axis.


  • Open Access

    A PNPLA3–NACC1–RIPK3 pathway mediates macrophage necroptosis and inflammation in MASLD

    by Xinjia Wang, Lu Bian, Zhuoying Feng, Kyle O’sHaughnessy, Andrew C. Kwong, Eun Hee Ha, Lei Wang, Weibo Chen, Xianfang Wu

    Background: The 148M variant of PNPLA3 is a major genetic risk factor for metabolic dysfunction–associated steatotic liver disease (MASLD), yet its macrophage-specific role remains unclear. We investigated how PNPLA3-148M alters macrophage behavior and multicellular liver pathology under lipotoxic stress. Methods: We used a human induced pluripotent stem cell (iPSC)-derived multicellular liver culture comprising hepatocytes, hepatic stellate cells (HSCs), and isogenic macrophages that differed only at PNPLA3 (148M vs. 148I). Cultures were exposed to lipotoxic conditions to induce MASLD. We quantified inflammatory cytokines, oxidative stress, hepatocyte lipid accumulation, and HSC activation. Macrophage death pathways were profiled (apoptosis, pyroptosis, necroptosis), with emphasis on RIPK3 expression and phosphorylation. Downstream effects on hepatocytes and HSCs were assessed. Results: Under lipotoxic stress, 148M macrophages amplified MASLD-like features. PNPLA3 transcripts were induced in macrophages—rising in iPSC-derived macrophages from lipotoxic cultures, and in Kupffer cells isolated from murine MASLD. Single-cell RNA-seq further confirmed PNPLA3 expression in human liver macrophage clusters, in addition to hepatocytes and HSCs. Although PNPLA3 mRNA was comparable between genotypes, 148M macrophages displayed higher PNPLA3 protein and increased necroptosis, evidenced by elevated RIPK3 expression and phosphorylation without changes in apoptosis or pyroptosis. Integrative analyses identified NACC1 as a key transcriptional regulator of RIPK3 , with NF-κB–linked upregulation of NACC1 in 148M macrophages. NACC1 inhibition (genetic or NIC3) reduced RIPK3, suppressed necroptosis, and lowered pro-inflammatory cytokine secretion. NIC3 additionally decreased hepatocyte lipid accumulation and ATP and diminished HSC activation markers. Conclusions: The PNPLA3 148M variant promotes MASLD through a macrophage-specific NF-κB–NACC1–RIPK3 axis that enhances necroptosis and inflammatory signaling, thereby exacerbating hepatocyte steatosis and HSC activation. NACC1 emerges as a tractable therapeutic target for genetically at-risk individuals.


  • Open Access

    Targeting m6A modification inhibits herpes virus 1 infection

    by Zhuoying Feng, Fanghang Zhou, Miaomiao Tan, Tingting Wang, Ying Chen, Wenwen Xu, Bin Li, Xin Wang, Xin Deng, Ming-Liang He